taurine has been researched along with Heart Failure in 54 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to examine the anti-atherogenic and anti-inflammatory effect of supplemental taurine prior to and following incremental exercise in patients with heart failure (HF)." | 9.24 | Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. ( Ahmadian, M; Aslani, E; Roshan, VD; Stannard, SR, 2017) |
| "In a double-blind and randomly designed study, 16 patients with heart failure were assigned to two groups: taurine (TG, n = 8) and placebo (PG, n = 8)." | 9.24 | Taurine Supplementation Improves Functional Capacity, Myocardial Oxygen Consumption, and Electrical Activity in Heart Failure. ( Ahmadian, M; Ashourpore, E; Dabidi Roshan, V, 2017) |
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 9.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 9.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| "To study the effects of different doses of taurine (Tau) on calcium ion concentration ([Ca2+]i) and ATPase on cardiocyte membrane of diastole heart failure rats." | 7.75 | [Antagonism for different doses of taurine on calcium overload in myocardial cells of diastole heart failure rat model]. ( Qu, Y; Zhang, Q; Zhang, T; Zhang, X, 2009) |
| "Oral treatment with taurine (CAS 107-35-7) of rabbits with congestive heart failure (CHF) caused by impairment of aortic valve dose-dependently improved hemodynamic and contractile indices of the heart and prolonged the animals' life." | 7.68 | Effects on heart membranes after taurine treatment in rabbits with congestive heart failure. ( Elizarova, EP; Medvedeva, NV; Orlova, TR, 1993) |
| "The therapeutic effects of 2-aminoethanesulfonic acid (taurine) were tested in animals with congestive heart failure (HF) simulated by aortic valve damage." | 7.68 | [Use of taurine in the treatment of experimental congestive heart failure]. ( Elizarova, EP; Fetisova, NI; Mit'kina, LI; Orlova, TsR; Ryff, IM, 1991) |
| "To examine the effect of daily treatment with taurine on improving the status of congestive heart failure (CHF), we used rabbits with artificially induced aortic regurgitation." | 7.67 | Beneficial effect of taurine in rabbits with chronic congestive heart failure. ( Awata, N; Azuma, J; Hamaguchi, T; Kishimoto, S; Ohta, H; Sawamura, A; Sperelakis, N; Takihara, K; Tanaka, Y, 1986) |
| "The loss of mechanical function in rat hearts subjected to either the calcium-paradox or global ischemia heart failure models was found to correlate with decreases in myocardial taurine levels." | 7.66 | Effect of taurine on calcium paradox and ischemic heart failure. ( Chovan, JP; Kramer, JH; Schaffer, SW, 1981) |
| "The clinical efficacy of 2 gm BID of oral taurine (2-aminoethane sulfonic acid) was studied in 24 patients with congestive heart failure (CHF)." | 7.66 | Therapy of congestive heart failure with orally administered taurine. ( Awata, N; Azuma, J; Harada, H; Hasegawa, H; Kishimoto, S; Ogura, K; Sawamura, A; Yamamura, Y, 1983) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 7.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "Myocardial taurine levels were correlated with pulmonary wedge pressure (PWP) in dogs with congestive heart failure (CHF)." | 7.65 | A relation between myocardial taurine contest and pulmonary wedge pressure in dogs with heart failure. ( Bressler, R; Frangakis, CJ; Grosso, DS; Newman, WH, 1977) |
| "The concentration of taurine in the left ventricular muscle of hearts of patients who died of chronic congestive heart failure was twice that of patients who died of other causes and had no cardiac pathology." | 7.65 | Taurine concentrations in congestive heart failure. ( Bressler, R; Huxtable, R, 1974) |
| "Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors." | 6.50 | The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. ( Azuma, J; Ito, T; Schaffer, S, 2014) |
| "Taurine is a non-essential amino acid that has received much attention." | 5.72 | Short-Communication: Short-Term Treatment with Taurine Prevents the Development of Cardiac Hypertrophy and Early Death in Hereditary Cardiomyopathy of the Hamster and Is Sex-Dependent. ( Bkaily, G; Jacques, D; Jazzar, A; Khalil, A; Najibeddine, H; Normand, A; Simon, Y, 2022) |
| "Taurine was effective for CHF patients on HDF in whom dry weight was difficult to control in spite of various medications." | 5.43 | Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure. ( Kawaguchi, H; Komatsu, M; Naganuma, T; Nitta, K; Okazaki, M; Shiohira, S; Tsuchiya, K, 2016) |
| "Taurine treatment significantly improved LV systolic and diastolic function, and there were persistent increases in activities of Akt/PKB and SOD, and the level of HO-1 protein." | 5.39 | Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. ( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013) |
| "The purpose of this study was to examine the anti-atherogenic and anti-inflammatory effect of supplemental taurine prior to and following incremental exercise in patients with heart failure (HF)." | 5.24 | Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. ( Ahmadian, M; Aslani, E; Roshan, VD; Stannard, SR, 2017) |
| "In a double-blind and randomly designed study, 16 patients with heart failure were assigned to two groups: taurine (TG, n = 8) and placebo (PG, n = 8)." | 5.24 | Taurine Supplementation Improves Functional Capacity, Myocardial Oxygen Consumption, and Electrical Activity in Heart Failure. ( Ahmadian, M; Ashourpore, E; Dabidi Roshan, V, 2017) |
| "Supplementation results in higher myocardial CoQ10, taurine, and carnitine levels and is associated with a reduction in left ventricular end-diastolic volume in patients with left ventricular dysfunction before revascularization." | 5.10 | Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. ( Barr, A; Errett, L; Freeman, M; Jeejeebhoy, F; Keith, M; Kurian, R; Mazer, D; McCall, M, 2002) |
| "We compared the effect of oral administration of taurine (3 g/day) and coenzyme Q10 (CoQ10) (30 mg/day) in 17 patients with congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, whose ejection fraction assessed by echocardiography was less than 50%." | 5.07 | Usefulness of taurine in chronic congestive heart failure and its prospective application. ( Awata, N; Azuma, J; Sawamura, A, 1992) |
| "In a double-blind, randomized, crossover, placebo-controlled study, we investigated the effects of adding taurine to the conventional treatment in 14 patients with congestive heart failure for a 4-week period." | 5.05 | Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. ( Awata, N; Azuma, J; Hamaguchi, T; Harada, H; Hasegawa, H; Ishiyama, T; Ohta, H; Sawamura, A; Takihara, K; Yamagami, T, 1985) |
| " Reduced myocardial levels of myo-inositol in the myocardium of MI animals point to altered phospholipid metabolism and membrane receptor function in heart failure." | 3.91 | Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction. ( Barupal, DK; Fan, S; Hammond, HK; Ichikawa, Y; McKirnan, MD; Patel, HH; Roth, DM; Zemljic-Harpf, AE; Zhang, Z, 2019) |
| "To study the effects of different doses of taurine (Tau) on calcium ion concentration ([Ca2+]i) and ATPase on cardiocyte membrane of diastole heart failure rats." | 3.75 | [Antagonism for different doses of taurine on calcium overload in myocardial cells of diastole heart failure rat model]. ( Qu, Y; Zhang, Q; Zhang, T; Zhang, X, 2009) |
| "Published clinical research, as well as various theoretical considerations, suggest that supplemental intakes of the 'metavitamins' taurine, coenzyme Q10, and L-carnitine, as well as of the minerals magnesium, potassium, and chromium, may be of therapeutic benefit in congestive heart failure." | 3.69 | Fish oil and other nutritional adjuvants for treatment of congestive heart failure. ( McCarty, MF, 1996) |
| "Oral treatment with taurine (CAS 107-35-7) of rabbits with congestive heart failure (CHF) caused by impairment of aortic valve dose-dependently improved hemodynamic and contractile indices of the heart and prolonged the animals' life." | 3.68 | Effects on heart membranes after taurine treatment in rabbits with congestive heart failure. ( Elizarova, EP; Medvedeva, NV; Orlova, TR, 1993) |
| "The therapeutic effects of 2-aminoethanesulfonic acid (taurine) were tested in animals with congestive heart failure (HF) simulated by aortic valve damage." | 3.68 | [Use of taurine in the treatment of experimental congestive heart failure]. ( Elizarova, EP; Fetisova, NI; Mit'kina, LI; Orlova, TsR; Ryff, IM, 1991) |
| "To examine the effect of daily treatment with taurine on improving the status of congestive heart failure (CHF), we used rabbits with artificially induced aortic regurgitation." | 3.67 | Beneficial effect of taurine in rabbits with chronic congestive heart failure. ( Awata, N; Azuma, J; Hamaguchi, T; Kishimoto, S; Ohta, H; Sawamura, A; Sperelakis, N; Takihara, K; Tanaka, Y, 1986) |
| "The content of taurine in the hypertrophied left ventricle is increased in congestive heart failure an in spontaneously hypertensive (SH) rats." | 3.66 | Platelet taurine in patients with arterial hypertension, myocardial failure or infarction. ( Himberg, JJ; Paasonen, MK; Penttilä, O; Solatunturi, E, 1980) |
| "The clinical efficacy of 2 gm BID of oral taurine (2-aminoethane sulfonic acid) was studied in 24 patients with congestive heart failure (CHF)." | 3.66 | Therapy of congestive heart failure with orally administered taurine. ( Awata, N; Azuma, J; Harada, H; Hasegawa, H; Kishimoto, S; Ogura, K; Sawamura, A; Yamamura, Y, 1983) |
| "The loss of mechanical function in rat hearts subjected to either the calcium-paradox or global ischemia heart failure models was found to correlate with decreases in myocardial taurine levels." | 3.66 | Effect of taurine on calcium paradox and ischemic heart failure. ( Chovan, JP; Kramer, JH; Schaffer, SW, 1981) |
| "High concentrations of taurine are found in the heart and these are increased still further in congestive heart failure." | 3.66 | Physiological and experimental regulation of taurine content in the heart. ( Azari, J; Chubb, J; Huxtable, RJ, 1980) |
| "Myocardial taurine levels were correlated with pulmonary wedge pressure (PWP) in dogs with congestive heart failure (CHF)." | 3.65 | A relation between myocardial taurine contest and pulmonary wedge pressure in dogs with heart failure. ( Bressler, R; Frangakis, CJ; Grosso, DS; Newman, WH, 1977) |
| "The concentration of taurine in the left ventricular muscle of hearts of patients who died of chronic congestive heart failure was twice that of patients who died of other causes and had no cardiac pathology." | 3.65 | Taurine concentrations in congestive heart failure. ( Bressler, R; Huxtable, R, 1974) |
| "Taurine has also attracted attention because it has beneficial actions in CHF, in part by its demonstrated inhibition of the harmful actions of the neurohumoral factors." | 2.50 | The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II. ( Azuma, J; Ito, T; Schaffer, S, 2014) |
| "Taurine is an abundant β-amino acid that regulates several events that dramatically influence the development of ischemia-reperfusion injury." | 2.50 | Effect of taurine on ischemia-reperfusion injury. ( Azuma, J; Ito, T; Jong, CJ; Schaffer, SW, 2014) |
| "Patients suffering from congestive heart failure exhibit impaired myocardial energy production, myocyte calcium overload and increased oxidative stress." | 2.43 | The management of conditioned nutritional requirements in heart failure. ( Allard, ML; Jeejeebhoy, KN; Sole, MJ, 2006) |
| "Taurine has recently been added to infant formulas (about 50 mg/L)." | 2.37 | Taurine: its biological role and clinical implications. ( Chesney, RW, 1985) |
| "Taurine is a non-essential amino acid that has received much attention." | 1.72 | Short-Communication: Short-Term Treatment with Taurine Prevents the Development of Cardiac Hypertrophy and Early Death in Hereditary Cardiomyopathy of the Hamster and Is Sex-Dependent. ( Bkaily, G; Jacques, D; Jazzar, A; Khalil, A; Najibeddine, H; Normand, A; Simon, Y, 2022) |
| "Taurine was effective for CHF patients on HDF in whom dry weight was difficult to control in spite of various medications." | 1.43 | Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure. ( Kawaguchi, H; Komatsu, M; Naganuma, T; Nitta, K; Okazaki, M; Shiohira, S; Tsuchiya, K, 2016) |
| "Taurine treatment significantly improved LV systolic and diastolic function, and there were persistent increases in activities of Akt/PKB and SOD, and the level of HO-1 protein." | 1.39 | Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats. ( Li, W; Lu, XH; Wang, GG; Xu, L; Zhao, X, 2013) |
| "In one fox with dilated cardiomyopathy that was tested, the myocardial taurine concentration was lower (1." | 1.28 | Dietary taurine deficiency and dilated cardiomyopathy in the fox. ( Gilmour, RF; Kallfelz, FA; King, JM; Moise, NS; Pacioretty, LM; Stipanuk, MH, 1991) |
| "The taurine content was estimated from blood platelets and from the right atrial appendage removed during open heart surgery in 43 patients suffering from ischaemic heart disease." | 1.26 | Taurine in human auricular myocardium and blood platelets. ( Himberg, JJ; Merikallio, E; Paasonen, MK; Penttilä, O; Siltanen, P; Solatunturi, E, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (44.44) | 18.7374 |
| 1990's | 9 (16.67) | 18.2507 |
| 2000's | 5 (9.26) | 29.6817 |
| 2010's | 12 (22.22) | 24.3611 |
| 2020's | 4 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Bkaily, G | 1 |
| Simon, Y | 1 |
| Normand, A | 1 |
| Jazzar, A | 1 |
| Najibeddine, H | 1 |
| Khalil, A | 1 |
| Jacques, D | 1 |
| Laflamme, DP | 1 |
| Li, C | 1 |
| Zhou, Y | 1 |
| Niu, Y | 1 |
| He, W | 1 |
| Wang, X | 1 |
| Zhang, X | 2 |
| Wu, Y | 1 |
| Zhang, W | 1 |
| Zhao, L | 1 |
| Zheng, H | 1 |
| Song, W | 1 |
| Gao, H | 1 |
| Dai, T | 1 |
| Yan, F | 1 |
| Gong, J | 1 |
| Liu, S | 1 |
| Ahmadian, M | 2 |
| Roshan, VD | 2 |
| Aslani, E | 1 |
| Stannard, SR | 1 |
| Dragan, S | 1 |
| Buleu, F | 1 |
| Christodorescu, R | 1 |
| Cobzariu, F | 1 |
| Iurciuc, S | 1 |
| Velimirovici, D | 1 |
| Xiao, J | 1 |
| Luca, CT | 1 |
| McKirnan, MD | 1 |
| Ichikawa, Y | 1 |
| Zhang, Z | 1 |
| Zemljic-Harpf, AE | 1 |
| Fan, S | 1 |
| Barupal, DK | 1 |
| Patel, HH | 1 |
| Hammond, HK | 1 |
| Roth, DM | 1 |
| Wang, GG | 1 |
| Li, W | 1 |
| Lu, XH | 1 |
| Zhao, X | 1 |
| Xu, L | 1 |
| Ito, T | 2 |
| Schaffer, S | 2 |
| Azuma, J | 13 |
| Averin, E | 1 |
| Shiohira, S | 1 |
| Komatsu, M | 1 |
| Okazaki, M | 1 |
| Naganuma, T | 1 |
| Kawaguchi, H | 1 |
| Nitta, K | 1 |
| Tsuchiya, K | 1 |
| Dabidi Roshan, V | 1 |
| Ashourpore, E | 1 |
| Qu, Y | 1 |
| Zhang, T | 1 |
| Zhang, Q | 1 |
| Sedova, EM | 1 |
| Magnitskaia, OV | 1 |
| Beyranvand, MR | 1 |
| Khalafi, MK | 1 |
| Choobineh, S | 1 |
| Parsa, SA | 1 |
| Piranfar, MA | 1 |
| Diercks, DB | 1 |
| Owen, K | 1 |
| Tolstikov, V | 1 |
| Sutter, M | 1 |
| Schaffer, SW | 3 |
| Jong, CJ | 1 |
| Allard, ML | 1 |
| Jeejeebhoy, KN | 1 |
| Sole, MJ | 1 |
| Huxtable, RJ | 1 |
| Chubb, J | 1 |
| Azari, J | 1 |
| Hasegawa, H | 4 |
| Awata, N | 8 |
| Sawamura, A | 8 |
| Harada, H | 5 |
| Ogura, K | 3 |
| Ohta, H | 5 |
| Yamauchi, K | 1 |
| Kishimoto, S | 6 |
| Kramer, JH | 1 |
| Chovan, JP | 1 |
| Takihara, K | 4 |
| Van Vleet, JF | 1 |
| Ferrans, VJ | 1 |
| Yamamura, Y | 1 |
| Paasonen, MK | 3 |
| Penttilä, O | 2 |
| Himberg, JJ | 2 |
| Solatunturi, E | 3 |
| Darsee, JR | 1 |
| Heymsfield, SB | 1 |
| Merikallio, E | 1 |
| Siltanen, P | 1 |
| Remme, WJ | 1 |
| Elizarova, EP | 3 |
| Orlova, TR | 1 |
| Medvedeva, NV | 1 |
| McCarty, MF | 1 |
| Novotny, MJ | 1 |
| Hogan, PM | 1 |
| Lombardini, JB | 1 |
| Solodushko, V | 1 |
| Jeejeebhoy, F | 1 |
| Keith, M | 1 |
| Freeman, M | 1 |
| Barr, A | 1 |
| McCall, M | 1 |
| Kurian, R | 1 |
| Mazer, D | 1 |
| Errett, L | 1 |
| Newman, WH | 1 |
| Frangakis, CJ | 1 |
| Grosso, DS | 1 |
| Bressler, R | 3 |
| Orlova, TsR | 2 |
| Ryff, IM | 2 |
| Fetisova, NI | 1 |
| Mit'kina, LI | 1 |
| Moise, NS | 1 |
| Pacioretty, LM | 1 |
| Kallfelz, FA | 1 |
| Stipanuk, MH | 1 |
| King, JM | 1 |
| Gilmour, RF | 1 |
| Faron, RA | 1 |
| Puchkova, VA | 1 |
| Petrusenko, AN | 1 |
| Rudzhianskaĭte, AF | 1 |
| Hamlin, RL | 1 |
| Buffington, CA | 1 |
| Dlouha, H | 1 |
| McBroom, MJ | 1 |
| Tenaglia, A | 1 |
| Cody, R | 1 |
| Hamaguchi, T | 3 |
| Tanaka, Y | 2 |
| Sperelakis, N | 1 |
| Yamagami, T | 1 |
| Ishiyama, T | 1 |
| Chesney, RW | 1 |
| Nieminen, ML | 1 |
| Fukuda, K | 1 |
| Peterson, MB | 1 |
| Mead, RJ | 1 |
| Welty, JD | 1 |
| Huxtable, R | 2 |
| Mestyán, J | 1 |
| Fekete, M | 1 |
| Soltész, G | 1 |
| Járai, I | 1 |
| Gáti, I | 1 |
| Preisz, J | 1 |
| Doszpod, J | 1 |
10 reviews available for taurine and Heart Failure
| Article | Year |
|---|---|
Key nutrients important in the management of canine myxomatous mitral valve disease and heart failure.
Topics: Animals; Dog Diseases; Dogs; Fatty Acids, Omega-3; Heart Failure; Heart Valve Diseases; Humans; Lysi | 2022 |
Benefits of multiple micronutrient supplementation in heart failure: A comprehensive review.
Topics: Amino Acids; Carnitine; Databases, Factual; Dietary Supplements; Energy Metabolism; Fatty Acids, Ome | 2019 |
The effect of taurine on chronic heart failure: actions of taurine against catecholamine and angiotensin II.
Topics: Angiotensin II; Animals; Catecholamines; Chronic Disease; Heart Failure; Humans; Renin-Angiotensin S | 2014 |
Effect of taurine on ischemia-reperfusion injury.
Topics: Animals; Calcium; Cell Death; Heart Failure; Humans; Myocardial Reperfusion Injury; Reactive Oxygen | 2014 |
The management of conditioned nutritional requirements in heart failure.
Topics: Animals; Calcium; Carnitine; Creatine; Energy Metabolism; Heart Failure; Homeostasis; Humans; Muscle | 2006 |
Interaction between the actions of taurine and angiotensin II.
Topics: Angiotensin II; Animals; Calcium; Cardiomegaly; Cell Size; Diuretics; Heart Failure; Humans; MAP Kin | 2000 |
Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress.
Topics: Angiotensin II; Animals; Calcium; Cardiomyopathies; Heart Failure; Humans; Muscle Proteins; Myocardi | 2000 |
Taurine involvement in retinal and heart muscle function.
Topics: Amino Acids, Sulfur; Animals; Cats; Cysteine; Deficiency Diseases; Heart; Heart Failure; Humans; Hyp | 1975 |
Nutrition and the heart.
Topics: Animals; Cachexia; Carnitine; Cat Diseases; Cats; Diet; Dog Diseases; Dogs; Heart Diseases; Heart Fa | 1989 |
Taurine: its biological role and clinical implications.
Topics: Animals; Bile Acids and Salts; Blood Platelets; Brain; Child; Epilepsy; Heart; Heart Failure; Humans | 1985 |
10 trials available for taurine and Heart Failure
| Article | Year |
|---|---|
Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure.
Topics: Aged; Anti-Inflammatory Agents; Biomarkers; Blood Platelets; C-Reactive Protein; Dietary Supplements | 2017 |
Use of taurine during rehabilitation after cardiac surgery.
Topics: Adult; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Chronic Disease; Female; Heart Failure; | 2015 |
Taurine Supplementation Improves Functional Capacity, Myocardial Oxygen Consumption, and Electrical Activity in Heart Failure.
Topics: Aged; Dietary Supplements; Double-Blind Method; Exercise Test; Female; Heart; Heart Failure; Hemodyn | 2017 |
[A clinical experience of taurine and trimetazidine use in premenopausal women with chronic heart failure].
Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exerci | 2010 |
Effect of taurine supplementation on exercise capacity of patients with heart failure.
Topics: Aged; Dietary Supplements; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Tau | 2011 |
Taurine for treatment of congestive heart failure in humans.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Heart Failure; Hu | 1983 |
Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group.
Topics: Biological Transport; Calcium; Heart Failure; Humans; Myocardium; Taurine | 1994 |
Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction.
Topics: Aged; Carnitine; Coenzymes; Dietary Supplements; Double-Blind Method; Female; Heart Failure; Humans; | 2002 |
Usefulness of taurine in chronic congestive heart failure and its prospective application.
Topics: Administration, Oral; Cardiomyopathy, Dilated; Chronic Disease; Coenzymes; Coronary Disease; Double- | 1992 |
Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Drug Th | 1985 |
34 other studies available for taurine and Heart Failure
| Article | Year |
|---|---|
Short-Communication: Short-Term Treatment with Taurine Prevents the Development of Cardiac Hypertrophy and Early Death in Hereditary Cardiomyopathy of the Hamster and Is Sex-Dependent.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Cricetinae; Female; Heart Fai | 2022 |
Deficiency of Pdk1 drives heart failure by impairing taurine homeostasis through Slc6a6.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Heart Failure; Homeostasis; Mice; Mice, Knock | 2023 |
Anti-heart failure mechanism of saponin extract of black ginseng based on metabolomics.
Topics: Animals; Arachidonic Acid; Beclin-1; Heart Failure; Metabolomics; Panax; Proto-Oncogene Proteins c-a | 2023 |
Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.
Topics: Animals; Echocardiography; Female; Heart Failure; Heart Ventricles; Inosine; Inositol; Male; Metabol | 2019 |
Taurine attenuates oxidative stress and alleviates cardiac failure in type I diabetic rats.
Topics: Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Diabetes Me | 2013 |
Effect of Taurine on Hemodiafiltration in Patients With Chronic Heart Failure.
Topics: Aged; Aged, 80 and over; Cardiovascular Agents; Chronic Disease; Drug Monitoring; Echocardiography; | 2016 |
[Antagonism for different doses of taurine on calcium overload in myocardial cells of diastole heart failure rat model].
Topics: Adenosine Triphosphatases; Animals; Calcium; Diastole; Disease Models, Animal; Female; Heart Failure | 2009 |
Urinary metabolomic analysis for the identification of renal injury in patients with acute heart failure.
Topics: Aged; Biomarkers; Creatinine; Discriminant Analysis; Female; Gas Chromatography-Mass Spectrometry; G | 2012 |
Physiological and experimental regulation of taurine content in the heart.
Topics: Amino Acids; Animals; Binding Sites; Biological Transport, Active; Calcium; Cardiomegaly; Cyclic AMP | 1980 |
Effect of taurine on calcium paradox and ischemic heart failure.
Topics: Adenosine Triphosphatases; Animals; Calcium; Coronary Disease; Heart Failure; In Vitro Techniques; M | 1981 |
Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits.
Topics: Animals; Aortic Valve Insufficiency; Body Weight; Heart Failure; Heart Rate; Hemodynamics; Organ Siz | 1984 |
Furazolidone-induced congestive cardiomyopathy in ducklings: lack of protection from selenium, vitamin E, and taurine supplements.
Topics: Animals; Cardiomyopathies; Ducks; Furazolidone; Heart Failure; Male; Poultry Diseases; Selenium; Tau | 1983 |
Therapy of congestive heart failure with orally administered taurine.
Topics: Administration, Oral; Adult; Aged; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oxy | 1983 |
Platelet taurine in patients with arterial hypertension, myocardial failure or infarction.
Topics: Aged; Blood Platelets; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Myocardial In | 1980 |
Decreased myocardial taurine levels and hypertaurinuria in a kindred with mitral-valve prolapse and congestive cardiomyopathy.
Topics: Adolescent; Adult; Aged; Amino Acids; Cardiomyopathies; Child; Child, Preschool; Consanguinity; Echo | 1981 |
Taurine in human auricular myocardium and blood platelets.
Topics: Adult; Blood Platelets; Coronary Disease; Female; Heart Atria; Heart Diseases; Heart Failure; Heart | 1982 |
Taurine for treatment of congestive heart failure.
Topics: Female; Heart Failure; Humans; Middle Aged; Taurine | 1982 |
Congestive heart failure. Drug therapy: central or peripheral approach?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Carnitine | 1993 |
Effects on heart membranes after taurine treatment in rabbits with congestive heart failure.
Topics: Animals; Aortic Valve; Calcium; Cyclic N-Oxides; Electrocardiography; Electron Spin Resonance Spectr | 1993 |
Fish oil and other nutritional adjuvants for treatment of congestive heart failure.
Topics: Carnitine; Chromium; Coenzymes; Dietary Fats; Fish Oils; Heart Failure; Humans; Magnesium; Minerals; | 1996 |
Inotropic interventions in the assessment of myocardial failure associated with taurine deficiency in domestic cats.
Topics: Animals; Blood Pressure; Cats; Dobutamine; Echocardiography; Female; Food, Fortified; Heart; Heart F | 1996 |
A relation between myocardial taurine contest and pulmonary wedge pressure in dogs with heart failure.
Topics: Animals; Blood Pressure; Cardiac Catheterization; Disease Models, Animal; Dogs; Heart Failure; Heart | 1977 |
[Use of taurine in the treatment of experimental congestive heart failure].
Topics: Animals; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Heart Failure; Hemod | 1991 |
Dietary taurine deficiency and dilated cardiomyopathy in the fox.
Topics: Animals; Carboxy-Lyases; Cardiomyopathy, Dilated; Echocardiography; Female; Foxes; Heart Failure; Li | 1991 |
[Pathomorphological and morphometric evaluation of a model of aortic insufficiency in rabbits treated with taurine].
Topics: Animals; Aortic Valve; Aortic Valve Insufficiency; Heart; Heart Failure; Hemodynamics; Male; Myocard | 1990 |
Atrial natriuretic factor in taurine-treated normal and cardiomyopathic hamsters.
Topics: Animals; Atrial Natriuretic Factor; Biological Assay; Cricetinae; Diuresis; Heart Failure; Mesocrice | 1986 |
Evidence for a taurine-deficiency cardiomyopathy.
Topics: Animals; Calcium; Cardiomyopathies; Cats; Dogs; Heart Failure; Humans; In Vitro Techniques; Myocardi | 1988 |
Beneficial effect of taurine in rabbits with chronic congestive heart failure.
Topics: Animals; Aortic Valve Insufficiency; Calcium; Chronic Disease; Drug Evaluation, Preclinical; Heart F | 1986 |
Blood platelets: accumulation and release of taurine.
Topics: Animals; Biological Transport, Active; Blood Platelets; Heart Failure; Humans; Hypertension; In Vitr | 1985 |
Taurine and failing heart: experimental and clinical aspects.
Topics: Aged; Animals; Body Weight; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; O | 1985 |
Free amino acids in congestive heart failure.
Topics: Amino Acids; Animals; Dogs; Female; Heart; Heart Failure; Male; Methionine; Myocardium; Organ Size; | 1973 |
Elevation of taurine in human congestive heart failure.
Topics: Aged; Aorta; Blood Pressure; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myo | 1974 |
Taurine concentrations in congestive heart failure.
Topics: Aged; Aging; Animals; Aorta; Brain Chemistry; Female; Heart Failure; Humans; Hypertension; Male; Mid | 1974 |
The postnatal changes in the circulating free amino acid pool in the newborn infant. 3. The plasma amino acid ratio in infants born after pregnancies complicated by toxaemia, placental infarction, impaired umbilical circulation and chronic maternal diseas
Topics: Amino Acids; Chronic Disease; Female; Glutamine; Glycine; Heart Defects, Congenital; Heart Failure; | 1971 |